BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23764154)

  • 1. Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia.
    Leban N; Jraba K; Chalghoum A; Hassine S; Elhayek D; Denden S; Lakhdhar R; Maatoug F; Gamra H; Braham H; Ben Chibani J; Khelil AH
    Diagn Pathol; 2013 Jun; 8():93. PubMed ID: 23764154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of the C3*F allele and the Leiden mutation of coagulation factor V in patients with severe coronary heart disease who survived myocardial infarction.
    Császár A; Duba J; Melegh B; Kramer J; Szalai C; Prohászka Z; Karádi I; Kovács M; Méhes K; Romics L; Füst G
    Exp Clin Immunogenet; 2001; 18(4):206-12. PubMed ID: 11872951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic markers with coronary heart disease (myocardial infarction)--a case-control study.
    Golabi P; Kshatriya GK; Kapoor AK
    J Indian Med Assoc; 1999 Jan; 97(1):6-7. PubMed ID: 10549177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [C3 complement polymorphism in patients suffering from obstructive chronic bronchopneumopathy in Tunisia].
    Leban N; Haj Khelil A; Daimi H; Denden S; Slimene F; Mehdouani K; Abdennaji Guenounou B; Lefranc G; Perrin P; Ben Chibani J
    Ann Biol Clin (Paris); 2007; 65(3):251-6. PubMed ID: 17502296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes: the genetics, outcomes, and lipids in type 2 diabetes (GOLD) study.
    Izar MC; Helfenstein T; Ihara SS; Relvas WG; Santos AO; Fischer SC; Pinto LE; Lopes IE; Pomaro DR; Fonseca MI; Bodanese LC; Moriguchi EH; Saraiva JF; Introcaso L; Souza AD; Scartezini M; Torres KP; Zagury L; Jardim PC; Costa EA; Tacito LH; Forti A; Magalhaes ME; Chacra AR; Bertolami MC; Loures-Vale AA; Barros MA; Xavier HT; Lyra R; Argamanijan D; Guimaraes A; Novazzi JP; Kasinski N; Afiune A; Martinez TL; Santos RD; Nicolau JC; Cesar LA; Povoa RM; Carvalho AC; Han SW; Fonseca FA;
    Atherosclerosis; 2009 May; 204(1):165-70. PubMed ID: 18823627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a DNA polymorphism of the apolipoprotein AI-CIII-AIV gene cluster with myocardial infarction in a Tunisian population.
    Sediri Y; Kallel A; Feki M; Mourali S; Elasmi M; Abdessalem S; Mechmeche R; Jemaa R; Kaabachi N
    Eur J Intern Med; 2011 Aug; 22(4):407-11. PubMed ID: 21767760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction in Tunisian patients.
    Kallel A; Ben Ali S; Sediri Y; Chabrak S; Elasmi M; Sanhaji H; Souheil O; Haj-Taieb S; Feki M; Mechmeche R; Jemaa R; Kaabachi N
    Clin Chem Lab Med; 2008; 46(8):1097-101. PubMed ID: 18590467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between hepatic lipase -514 C/T promoter polymorphism and myocardial infarction is modified by history of hypercholesterolemia and waist circumference.
    Baylin A; Ruiz-Narvaez E; Jensen MK; Rimm E; Campos H
    Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):498-504. PubMed ID: 19695855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease.
    Elmgreen J; Sørensen H; Berkowicz A
    Acta Med Scand; 1984; 215(4):375-8. PubMed ID: 6731047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.
    Xu Z; Yu L; Zhang X
    Diagn Pathol; 2013 Aug; 8():144. PubMed ID: 23971971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive effects of interferon-gamma functional single nucleotid polymorphism (+874 T/A) with cardiovascular risk factors in coronary heart disease and early myocardial infarction risk.
    Akadam-Teker AB; Teker E; Daglar-Aday A; Pekkoc-Uyanik KC; Aslan EI; Kucukhuseyin Ö; Ozkara G; Yılmaz-Aydoğan H
    Mol Biol Rep; 2020 Nov; 47(11):8397-8405. PubMed ID: 33104992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of rs1883832 and rs4810485 polymorphisms of CD40 gene with myocardial infarction in the Tunisian population.
    Soussi M; Kallel A; Ben Wafi S; Ben Halima M; Sanhaji H; Mourali MS; Jemaa R; Feki M
    Biomarkers; 2019 Sep; 24(6):530-537. PubMed ID: 30924686
    [No Abstract]   [Full Text] [Related]  

  • 13. CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
    Haberbosch W; Unkelbach K; Schuster D; Gardemann A; Tillmanns H; Hölschermann H
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):386-90. PubMed ID: 19795323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of I/D polymorphism of angiotensin-converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients.
    Hmimech W; Idrissi HH; Diakite B; Korchi F; Baghdadi D; Tahri Joutey Hassani Idrissi H; Haboub M; Habbal R; Nadifi S
    BMC Res Notes; 2017 Dec; 10(1):763. PubMed ID: 29268798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between factor V Leiden and prothrombin G20210A polymorphisms in Tunisian subjects with a history of myocardial infarction.
    Berredjeb Ben Slama D; Fekih-Mrissa N; Haggui A; Nsiri B; Baraket N; Haouala H; Gritli N
    Cardiovasc Pathol; 2013; 22(1):39-41. PubMed ID: 22483732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association analysis of myocardial infarction with thrombospondin-1 N700S variant in a Chinese population.
    Zhou X; Huang J; Chen J; Zhao J; Ge D; Yang W; Gu D
    Thromb Res; 2004; 113(3-4):181-6. PubMed ID: 15140581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels.
    Gigante B; Leander K; Vikström M; Ye S; de Faire U
    BMC Cardiovasc Disord; 2012 Oct; 12():90. PubMed ID: 23067240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study.
    Kardys I; Klaver CC; Despriet DD; Bergen AA; Uitterlinden AG; Hofman A; Oostra BA; Van Duijn CM; de Jong PT; Witteman JC
    J Am Coll Cardiol; 2006 Apr; 47(8):1568-75. PubMed ID: 16630992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of myocardial infarction among Tunisian male patients.
    Kallel A; Abdessalem S; Sédiri Y; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N
    Clin Biochem; 2012 Apr; 45(6):420-4. PubMed ID: 22285384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population.
    Kallel A; Sbaï MH; Sediri Y; Abdessalem S; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N
    Cytokine; 2013 Dec; 64(3):646-51. PubMed ID: 24095258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.